Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bleeding complications after hematopoietic stem cell transplantation.

Markus Pihusch1

  • 1Bone Marrow Transplantation Unit, 1st Department of Internal Medicine, University of Regensburg, Germany.

Seminars in Hematology
|February 12, 2004
PubMed
Summary

Hematopoietic stem cell transplantation (HSCT) patients frequently experience bleeding due to graft-versus-host disease (GvHD) and antithymocyte globulin (ATG). Understanding these hemostatic disturbances is crucial for managing bleeding risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endothelial cell-derived microparticles in allogeneic hematopoietic stem cell recipients.

Transplantation·2006
Same author

Evaluation of C-reactive protein, interleukin-6, and procalcitonin levels in allogeneic hematopoietic stem cell recipients.

European journal of haematology·2006
Same author

Diagnosis of hepatic veno-occlusive disease by plasminogen activator inhibitor-1 plasma antigen levels: a prospective analysis in 350 allogeneic hematopoietic stem cell recipients.

Transplantation·2005
Same author

Peripheral dendritic cell chimerism in allogeneic hematopoietic stem cell recipients.

Transplantation·2005
Same author

Transforming growth factor beta-1 released from platelets contributes to hypercoagulability in veno-occlusive disease following hematopoetic stem cell transplantation.

Thrombosis research·2005
Same author

Impact of thrombophilic gene mutations and graft-versus-host disease on thromboembolic complications after allogeneic hematopoietic stem-cell transplantation.

Transplantation·2004

Area of Science:

  • Hematology
  • Immunology
  • Transplantation Medicine

Background:

  • Hemostatic disturbances are prevalent in hematopoietic stem cell transplantation (HSCT), significantly impacting patient outcomes.
  • Graft-versus-host disease (GvHD) is strongly linked to bleeding episodes, indicating a complex interplay between immune and hemostatic systems.
  • Factor XIII (FXIII) deficiency in gut GvHD and antithymocyte globulin (ATG) use are identified risk factors for hemorrhage.

Purpose of the Study:

  • To examine the causes and incidence of bleeding complications in HSCT patients.
  • To investigate the contributions of GvHD and ATG to bleeding events.
  • To explore the intricate relationship between the hemostatic and immune systems in the context of HSCT.

Main Methods:

  • Review of literature on bleeding complications in HSCT.

Related Experiment Videos

  • Analysis of the impact of GvHD on hemostasis.
  • Evaluation of antithymocyte globulin (ATG) as a contributing factor to bleeding.

    • Main Results:

    • GvHD significantly correlates with increased bleeding incidence and severity.
    • Factor XIII deficiency is observed in patients with GvHD of the gut.
    • Antithymocyte globulin (ATG) may induce leukopenia, thrombocytopenia, and disseminated intravascular coagulation (DIC).

    Conclusions:

    • Bleeding complications in HSCT are multifactorial, involving GvHD and therapeutic agents like ATG.
    • The interaction between immunological responses (GvHD) and hemostatic pathways is critical in HSCT-associated bleeding.
    • Further research into agents like recombinant FVIIa for managing HSCT-related hemorrhage is warranted.